Digipath Inc
OTC:DIGP
Profitability Summary
Digipath Inc's profitability score is 32/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Score
Score
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Digipath Inc
|
Revenue
|
0
USD
|
|
Operating Expenses
|
-821.2k
USD
|
|
Operating Income
|
-821.2k
USD
|
|
Other Expenses
|
1.8m
USD
|
|
Net Income
|
942.1k
USD
|
Margins Comparison
Digipath Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| US |
|
Digipath Inc
OTC:DIGP
|
3.4m USD | N/A | N/A | N/A | |
| US |
C
|
Cigna Group
XMUN:CGN
|
75.9B EUR |
10%
|
4%
|
2%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
84.4B USD |
10%
|
4%
|
2%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
76B USD |
14%
|
3%
|
1%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
30.9B EUR |
24%
|
7%
|
3%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR |
25%
|
8%
|
2%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
20.3B USD |
28%
|
9%
|
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
19B USD |
33%
|
14%
|
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
15.4B EUR |
24%
|
7%
|
3%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
12B USD |
77%
|
6%
|
9%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD |
32%
|
15%
|
7%
|
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
Return on Capital Comparison
Digipath Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Digipath Inc
OTC:DIGP
|
3.4m USD |
-69%
|
75%
|
66%
|
-187%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
75.9B EUR |
12%
|
3%
|
10%
|
6%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
84.4B USD |
12%
|
3%
|
10%
|
6%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
76B USD |
7%
|
2%
|
6%
|
4%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
30.9B EUR |
4%
|
2%
|
5%
|
3%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR |
2%
|
1%
|
5%
|
3%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
20.3B USD |
9%
|
4%
|
8%
|
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
19B USD |
13%
|
6%
|
11%
|
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
15.4B EUR |
4%
|
2%
|
5%
|
3%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
12B USD |
37%
|
25%
|
24%
|
48%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD |
261%
|
5%
|
13%
|
10%
|
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
You don't have any saved screeners yet
